Related Experiment Video
Updated: Jul 26, 2025

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia
Published on: November 15, 2024
Hyperglycemia Aggravates the Cerebral Ischemia Injury via Protein O-GlcNAcylation
Jing Zhu1,2, Xin Ji3,2, Ruirui Shi2
1Department of Rehabilitation Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China.
Insights
Protein O-GlcNAcylation worsens ischemic stroke injury in hyperglycemia, contrary to its protective effects in normal conditions. Blocking this modification alleviates injury, suggesting it as a therapeutic target for stroke in diabetic patients.
Area of Science:
- Neuroscience
- Biochemistry
- Pathology
Background:
- Alzheimer's disease (AD) patients frequently exhibit cerebrovascular issues, increasing stroke risk.
- Hyperglycemia exacerbates vascular damage and cerebral ischemia, posing a significant threat.
- Protein O-GlcNAcylation is known to protect against ischemic stroke, but its role in hyperglycemia-induced exacerbation is unclear.
Purpose of the Study:
- To investigate the mechanism by which protein O-GlcNAcylation exacerbates cerebral ischemia injury under hyperglycemic conditions.
- To explore the therapeutic potential of targeting protein O-GlcNAcylation in hyperglycemia-related ischemic stroke.
Main Methods:
- Utilized high glucose-cultured brain microvascular endothelial (bEnd3) cells subjected to oxygen-glucose deprivation.
- Assessed cell viability, stroke outcomes, and hemorrhagic transformation in hyperglycemic mice after middle cerebral artery occlusion.
- Employed Western blot to analyze apoptosis levels and the impact of O-GlcNAcylation modulation.
Main Results:
- Upregulating O-GlcNAcylation with Thiamet-G attenuated injury in normal glucose but aggravated it in high glucose conditions.
- In vivo, Thiamet-G worsened ischemic injury and hemorrhagic transformation, increasing apoptosis.
- Inhibiting O-GlcNAcylation with 6-diazo-5-oxo-L-norleucine ameliorated cerebral injury in hyperglycemic mice.
Conclusions:
- Protein O-GlcNAcylation plays a critical role in exacerbating cerebral ischemia injury during hyperglycemia.
- Targeting O-GlcNAcylation presents a potential therapeutic strategy for ischemic stroke in hyperglycemic individuals, including those with AD.
Background:
At least one-third of Alzheimer's disease (AD) patients have cerebrovascular abnormalities, micro- and macro-infarctions, and ischemic white matter alterations. Stroke prognosis impacts AD development due to vascular disease. Hyperglycemia can readily produce vascular lesions and atherosclerosis, increasing the risk of cerebral ischemia. Our previous research has demonstrated that protein O-GlcNAcylation, a dynamic and reversible post-translational modification, provides protection against ischemic stroke. However, the role of O-GlcNAcylation in the exacerbation of cerebral ischemia injury due to hyperglycemia remains to be elucidated.
Objective:
In this study, we explored the role and underlying mechanism of protein O-GlcNAcylation in the exacerbation of cerebral ischemia injury caused by hyperglycemia.
Methods:
High glucose-cultured brain microvascular endothelial (bEnd3) cells were injured by oxygen-glucose deprivation. Cell viability was used as the assay result. Stroke outcomes and hemorrhagic transformation incidence were assessed in mice after middle cerebral artery occlusion under high glucose and streptozotocin-induced hyperglycemic conditions. Western blot estimated that O-GlcNAcylation influenced apoptosis levels in vitro and in vivo.
Results:
In in vitro analyses showed that Thiamet-G induces upregulation of protein O-GlcNAcylation, which attenuates oxygen-glucose deprivation/R-induce injury in bEnd3 cells cultured under normal glucose conditions, while aggravated it under high glucose conditions. In in vivo analyses, Thiamet-G exacerbated cerebral ischemic injury and induced hemorrhagic transformation, accompanied by increased apoptosis. While blocking protein O-GlcNAcylation with 6-diazo-5-oxo-L-norleucine alleviated cerebral injury of ischemic stroke in different hyperglycemic mice.
Conclusion:
Overall, our study highlights the crucial role of O-GlcNAcylation in exacerbating cerebral ischemia injury under conditions of hyperglycemia. O-GlcNAcylation could potentially serve as a therapeutic target for ischemic stroke associated with AD.
Related Concept Videos
Hypoglycemia and Glucagon
Proteoglycans
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...

